+ Follow LOVISCOL Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 840755
[Title] => Pfizer says product recall only due to incorrect declaration
[Summary] => Pharmaceutical giant Pfizer Consumer Health yesterday assured the public that the recall of Carbocisteine (Loviscol) 50 mg/mL syrup (oral drops) has nothing to do with the efficacy of the medicine.
[DatePublished] => 2012-08-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[1] => Array
(
[ArticleID] => 840410
[Title] => Cough syrup ordered recalled
[Summary] => The Food and Drug Administration (FDA) has ordered Pfizer Consumer Healthcare to pull out from the market some batches of a cough syrup due to incorrect declaration of concentration.
[DatePublished] => 2012-08-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[2] => Array
(
[ArticleID] => 616693
[Title] => Pfizer chooses MEC Philippines
[Summary] => Pfizer appointed MEC Philippines in handling their on-and off-line media planning and buying, effective immediately.
[DatePublished] => 2010-10-01 17:03:48
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
LOVISCOL
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 840755
[Title] => Pfizer says product recall only due to incorrect declaration
[Summary] => Pharmaceutical giant Pfizer Consumer Health yesterday assured the public that the recall of Carbocisteine (Loviscol) 50 mg/mL syrup (oral drops) has nothing to do with the efficacy of the medicine.
[DatePublished] => 2012-08-22 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[1] => Array
(
[ArticleID] => 840410
[Title] => Cough syrup ordered recalled
[Summary] => The Food and Drug Administration (FDA) has ordered Pfizer Consumer Healthcare to pull out from the market some batches of a cough syrup due to incorrect declaration of concentration.
[DatePublished] => 2012-08-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[2] => Array
(
[ArticleID] => 616693
[Title] => Pfizer chooses MEC Philippines
[Summary] => Pfizer appointed MEC Philippines in handling their on-and off-line media planning and buying, effective immediately.
[DatePublished] => 2010-10-01 17:03:48
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
abtest